Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein

R&D Systems, part of Bio-Techne | Catalog # 6996-IL

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Carrier Free
6996-IL-010/CF
Catalog #
Availability
Size / Price
Qty
With Carrier
6996-IL-010
Print Quote
Bulk Order
100% Guarantee

Key Product Details

  • R&D Systems E. coli-derived Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein (6996-IL)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession #

Q8R460

Structure / Form

Monomer

Conjugate

Unconjugated

Applications

Bioactivity

View all IL-36 gamma/IL-1F9 Proteins and Enzymes »

Product Specifications

Source

E. coli-derived mouse IL-36 gamma/IL-1F9 protein
Gly13-Ser164

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Gly13

Predicted Molecular Mass

17.3 kDa

SDS-PAGE

17 kDa, reducing conditions

Activity

Measured by its ability to induce IL-6 secretion by NIH-3T3 mouse embryonic fibroblast cells. Towne, J.E. et al. (2004) J. Biol. Chem. 279:13677.
The ED50 for this effect is 3-18 ng/mL.

Reviewed Applications

Read 1 review rated 4 using 6996-IL in the following applications:

Scientific Data Images for Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein

Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein Bioactivity

Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein Bioactivity

Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) (Catalog # 6996-IL) induces IL-6 secretion in the NIH‑3T3 mouse embryonic fibroblast cell line. The ED50 for this effect is 3-18 ng/mL.
Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein SDS-PAGE

Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein SDS-PAGE

1 µg/lane of Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) was resolved with SDS-PAGE under reducing (R) conditions and visualized by silver staining, showing a single band at 17 kDa.

Formulation, Preparation and Storage

Carrier Free
What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Carrier: 6996-IL
Formulation Lyophilized from a 0.2 μm filtered solution in MES, NaCl, TCEP, EDTA, CHAPS and PEG 8000 with BSA as a carrier protein.
Reconstitution Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Carrier Free: 6996-IL/CF
Formulation Lyophilized from a 0.2 μm filtered solution in MES, NaCl, TCEP, EDTA, CHAPS and PEG 8000 with Trehalose.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: IL-36 gamma/IL-1F9

IL-36 gamma [previously called IL-1F9, IL-1 epsilon (epsilon), and IL-1H1] is a member of the IL-1 family which includes IL‑1 beta, IL‑1 alpha, IL‑1ra, IL‑18, IL‑36 Ra (IL‑1F5), IL-36 alpha (IL‑1F6), IL‑36 beta (IL‑1F8), IL‑37 (IL‑1F7) and IL-1F10 (1-5). All family members show a 12  beta-strand, beta‑trefoil configuration, and are believed to have arisen from a common ancestral gene (2, 3). Mouse IL‑36 gamma is an 18-22 kDa, 164 amino acid (aa) intracellular and secreted protein that contains no signal sequence, no prosegment and no potential N‑linked glycosylation sites (1, 2, 4, 6, 7). Mouse IL‑36 gamma (aa 13-164) shares 58%, 84%, 64% and 60% aa sequence identity with human, rat, equine and bovine IL‑36 gamma, respectively, and 23-57% aa sequence identity with other family members. A 193 aa mouse isoform with a 29 aa N‑terminal extension has been reported (8). Highest levels of IL‑36 gamma are produced by Langerhans cells, keratinocytes, and stomach Chief cells and parietal cells; these cells contribute to first‑line defense against pathogens in the skin, lungs and digestive tract (2, 3, 6, 9). Its expression is induced by LPS treatment of monocytes, and by IL‑ alpha/ beta, IL‑17 or TNF‑ alpha treatment of keratinocytes and bronchial epithelia (1, 6, 7, 9-11). Skin IL-36 gamma expression is increased in contact hypersensitivity and psoriasis (1, 6, 11). It is elevated in inflammatory disorders of the lung (such as asthma) and viral infections. Lung IL‑36 gamma and other IL‑36 proteins contribute to neutrophil influx (4, 7, 10). The receptor for IL-36 gamma is a combination of IL‑1 Rrp2, mainly found in epithelia and keratinocytes, and the widely expressed IL‑1 RAcP (4, 7, 9). IL‑36 alpha, beta and gamma all activate NF‑ kappaB and MAPK pathways in an IL‑1 Rrp2 dependent manner, and IL‑36 gamma induces production of inflammatory cytokines and chemokines such as CXCL8/IL‑8 (7, 9, 10). Full-length recombinant IL-36 proteins appear less active than their endogenous counterparts, but trimming of the N-termini enhances their activity (12).

References

  1. Kumar, S. et al. (2000) J. Biol. Chem. 275:10308.
  2. Busfield, S.J. et al. (2000) Genomics 66:213.
  3. Dunn, E. et al. (2001) Trends Immunol. 22:533.
  4. Barksby, H.E. et al. (2007) Clin. Exp. Immunol. 149:217.
  5. Dinarello, C. et al. (2010) Nat. Immunol. 11:973.
  6. Debets, R. et al. (2001) J. Immunol. 167:1440.
  7. Chustz, R.T. et al. (2010) Am. J. Respir. Cell Mol. Biol. 45:145.
  8. NCBI Accession # NP_705731.2.
  9. Towne, J.E. et al. (2004) J. Biol. Chem. 279:13677.
  10. Ramadas, R.A. et al. (2011) Am. J. Respir. Cell Mol. Biol. 44:134.
  11. Johnston, A. et al. (2011) J. Immunol. 186:2613.
  12. Blumberg, H. et al. (2010) J. Immunol. 185:4354.

Long Name

Interleukin 36 gamma/Interleukin 1 Family 9

Alternate Names

IL-1 H1, IL-1rp2, IL1F9, IL36 gamma, IL36G

Entrez Gene IDs

56300 (Human); 215257 (Mouse); 499744 (Rat)

Gene Symbol

IL36G

UniProt

Q8R460

Additional IL-36 gamma/IL-1F9 Products

Product Documents for Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS 6996-IL (with carrier)
Download SDS 6996-IL/CF (carrier free)

Product Specific Notices for Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) Protein

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2026 Bio-Techne. All Rights Reserved.